LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy.

    Gili, Tommaso / Benelli, Giampaolo / Buscarini, Elisabetta / Canetta, Ciro / La Piana, Giuseppe / Merli, Guido / Scartabellati, Alessandro / Viganò, Giovanni / Sfogliarini, Roberto / Melilli, Giovanni / Assandri, Roberto / Cazzato, Daniele / Rossi, Davide Sebastiano / Usai, Susanna / Caldarelli, Guido / Tramacere, Irene / Pellegata, Germano / Lauria, Giuseppe

    PloS one

    2021  Volume 16, Issue 3, Page(s) e0248498

    Abstract: ... network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and ... a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 ... swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy ...

    Abstract We report onset, course, correlations with comorbidities, and diagnostic accuracy of nasopharyngeal swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy. All individuals underwent clinical and laboratory exams, SARS-COV-2 reverse transcriptase-polymerase chain reaction on nasopharyngeal swab, and chest X-ray and/or computed tomography (CT). Data on onset, course, comorbidities, number of drugs including angiotensin converting enzyme (ACE) inhibitors and angiotensin-II-receptor antagonists (sartans), follow-up swab, pharmacological treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Among 411 SARS-COV-2 patients (67.7% males) median age was 70.8 years (range 5-99). Chest CT was performed in 317 (77.2%) and showed interstitial pneumonia in 304 (96%). Fatality rate was 17.5% (74% males), with 6.6% in 60-69 years old, 21.1% in 70-79 years old, 38.8% in 80-89 years old, and 83.3% above 90 years. No death occurred below 60 years. Non-invasive respiratory support rate was 27.2% and ICU admission 6.8%. Charlson comorbidity index and high C-reactive protein at admission were significantly associated with death. Use of ACE inhibitors or sartans was not associated with outcomes. Among 128 swab negative patients at admission (63.3% males) median age was 67.7 years (range 1-98). Chest CT was performed in 87 (68%) and showed interstitial pneumonia in 76 (87.3%). Follow-up swab turned positive in 13 of 32 patients. Using chest CT at admission as gold standard on the entire study population of 539 patients, nasopharyngeal swab had 80% accuracy. Comorbidity network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 caused high mortality among patients older than 60 years and correlated with pre-existing multiorgan impairment.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; C-Reactive Protein/analysis ; COVID-19/drug therapy ; COVID-19/mortality ; COVID-19/pathology ; COVID-19/virology ; Child ; Child, Preschool ; Comorbidity ; Female ; Hospitalization/statistics & numerical data ; Humans ; Italy ; Male ; Middle Aged ; Risk Factors ; SARS-CoV-2/isolation & purification ; Treatment Outcome ; Young Adult
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2021-03-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0248498
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy.

    Tommaso Gili / Giampaolo Benelli / Elisabetta Buscarini / Ciro Canetta / Giuseppe La Piana / Guido Merli / Alessandro Scartabellati / Giovanni Viganò / Roberto Sfogliarini / Giovanni Melilli / Roberto Assandri / Daniele Cazzato / Davide Sebastiano Rossi / Susanna Usai / Guido Caldarelli / Irene Tramacere / Germano Pellegata / Giuseppe Lauria

    PLoS ONE, Vol 16, Iss 3, p e

    2021  Volume 0248498

    Abstract: ... network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and ... a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 ... swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy ...

    Abstract We report onset, course, correlations with comorbidities, and diagnostic accuracy of nasopharyngeal swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy. All individuals underwent clinical and laboratory exams, SARS-COV-2 reverse transcriptase-polymerase chain reaction on nasopharyngeal swab, and chest X-ray and/or computed tomography (CT). Data on onset, course, comorbidities, number of drugs including angiotensin converting enzyme (ACE) inhibitors and angiotensin-II-receptor antagonists (sartans), follow-up swab, pharmacological treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Among 411 SARS-COV-2 patients (67.7% males) median age was 70.8 years (range 5-99). Chest CT was performed in 317 (77.2%) and showed interstitial pneumonia in 304 (96%). Fatality rate was 17.5% (74% males), with 6.6% in 60-69 years old, 21.1% in 70-79 years old, 38.8% in 80-89 years old, and 83.3% above 90 years. No death occurred below 60 years. Non-invasive respiratory support rate was 27.2% and ICU admission 6.8%. Charlson comorbidity index and high C-reactive protein at admission were significantly associated with death. Use of ACE inhibitors or sartans was not associated with outcomes. Among 128 swab negative patients at admission (63.3% males) median age was 67.7 years (range 1-98). Chest CT was performed in 87 (68%) and showed interstitial pneumonia in 76 (87.3%). Follow-up swab turned positive in 13 of 32 patients. Using chest CT at admission as gold standard on the entire study population of 539 patients, nasopharyngeal swab had 80% accuracy. Comorbidity network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 caused high mortality among patients older than 60 years and correlated with pre-existing multiorgan impairment.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610 ; 616
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy

    Benelli, Gianpaolo / Buscarini, Elisabetta / Canetta, Ciro / La Piana, Giuseppe / Merli, Guido / Scartabellati, Alessandro / Vigano, Giovanni / Sfogliarini, Roberto / Melilli, Giovanni / Assandri, Roberto / Cazzato, Daniele / Rossi, Davide Sebastiano / Usai, Susanna / Caldarelli, Guido / Gili, Tommaso / Tramacere, Irene / Pellegata, Germano / Lauria, Giuseppe

    medRxiv

    Abstract: ... in 74% and negative in 3.2%. Six patients died within 72 hours; another 66 during hospitalization ... chest X-ray and/or computed tomography (CT) and SARS-COV-2 assay on nasopharyngeal swab. Onset symptoms ... up. Using CT as reference, nasopharyngeal swab had 80% sensitivity. Comorbidity network ...

    Abstract Objective To provide Covid-19 fatality rate, correlations with comorbidities and sensitivity of nasopharingeal swab. Design Prospective cohort study performed between February 21th and March 19rd, 2020 Setting Hospital-based study Participants Of 2,217 admitted, 766 consecutive individuals either reporting or presenting with fever, cough or dyspnea, and suspected to carry Covid-19 infection were examined. Intervention All individuals underwent body temperature and pulse oximetry recording, hematological screening, chest X-ray and/or computed tomography (CT) and SARS-COV-2 assay on nasopharyngeal swab. Onset symptoms, course, comorbidities, number of drugs, use of angiotensin converting enzyme inhibitors and angiotensin-II-receptor antagonists, and follow-up swab, clinical, hematological, and radiological exams, treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Main outcome measures Primary outcomes were non-invasive respiratory support, intensive care unit (ICU) admission, and death. Results Median age of 411 Covid-19 patients was 70.5 years (range 1-99; 66.6% males). CT was positive in 74% and negative in 3.2%. Six patients died within 72 hours; another 66 during hospitalization. Fatality rate was 17.5% (74% males). No death occurred below 60 years. Mortality was 6.6% in 60-69 decade, 21.1% in 70-79, 38.8% in 80-89, and 83.3% above 90 years. Non-invasive respiratory support rate was 27.2%; ICU admission 6.8%. Older age, cough and dyspnea at onset, hypertension, cardiovascular diseases, diabetes, renal insufficiency, >7 drugs intake and positive X-ray at admission were significantly associated with death. Low lymphocyte count, high C-reactive protein, aspartate aminotransferase and lactate dehydrogenase, and low PO2 partial pressure with high lactate at arterial blood gas analysis at admission were also significantly associated with death. Of 32 swab negative patients, 40.6% turned positive at follow-up. Using CT as reference, nasopharyngeal swab had 80% sensitivity. Comorbidity network analysis revealed homogenous distribution of deceased and 60-80 aged patients across diseases. Conclusions Covid-19 caused high mortality among patients older than 70 years and correlated by pre-existing multiorgan impairment irrespective of the age.
    Keywords covid19
    Language English
    Publishing date 2020-04-20
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.04.14.20053090
    Database COVID19

    Kategorien

  4. Article ; Online: SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy

    Benelli, Gianpaolo / Buscarini, Elisabetta / Canetta, Ciro / La Piana, Giuseppe / Merli, Guido / Scartabellati, Alessandro / Vigano, Giovanni / Sfogliarini, Roberto / Melilli, Giovanni / Assandri, Roberto / Cazzato, Daniele / Rossi, Davide Sebastiano / Usai, Susanna / Caldarelli, Guido / Gili, Tommaso / Tramacere, Irene / Pellegata, Germano / Lauria, Giuseppe

    Abstract: ... in 74% and negative in 3.2%. Six patients died within 72 hours; another 66 during hospitalization ... chest X-ray and/or computed tomography (CT) and SARS-COV-2 assay on nasopharyngeal swab. Onset symptoms ... up. Using CT as reference, nasopharyngeal swab had 80% sensitivity. Comorbidity network ...

    Abstract Objective To provide Covid-19 fatality rate, correlations with comorbidities and sensitivity of nasopharingeal swab. Design Prospective cohort study performed between February 21th and March 19rd, 2020 Setting Hospital-based study Participants Of 2,217 admitted, 766 consecutive individuals either reporting or presenting with fever, cough or dyspnea, and suspected to carry Covid-19 infection were examined. Intervention All individuals underwent body temperature and pulse oximetry recording, hematological screening, chest X-ray and/or computed tomography (CT) and SARS-COV-2 assay on nasopharyngeal swab. Onset symptoms, course, comorbidities, number of drugs, use of angiotensin converting enzyme inhibitors and angiotensin-II-receptor antagonists, and follow-up swab, clinical, hematological, and radiological exams, treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Main outcome measures Primary outcomes were non-invasive respiratory support, intensive care unit (ICU) admission, and death. Results Median age of 411 Covid-19 patients was 70.5 years (range 1-99; 66.6% males). CT was positive in 74% and negative in 3.2%. Six patients died within 72 hours; another 66 during hospitalization. Fatality rate was 17.5% (74% males). No death occurred below 60 years. Mortality was 6.6% in 60-69 decade, 21.1% in 70-79, 38.8% in 80-89, and 83.3% above 90 years. Non-invasive respiratory support rate was 27.2%; ICU admission 6.8%. Older age, cough and dyspnea at onset, hypertension, cardiovascular diseases, diabetes, renal insufficiency, >7 drugs intake and positive X-ray at admission were significantly associated with death. Low lymphocyte count, high C-reactive protein, aspartate aminotransferase and lactate dehydrogenase, and low PO2 partial pressure with high lactate at arterial blood gas analysis at admission were also significantly associated with death. Of 32 swab negative patients, 40.6% turned positive at follow-up. Using CT as reference, nasopharyngeal swab had 80% sensitivity. Comorbidity network analysis revealed homogenous distribution of deceased and 60-80 aged patients across diseases. Conclusions Covid-19 caused high mortality among patients older than 70 years and correlated by pre-existing multiorgan impairment irrespective of the age.
    Keywords covid19
    Publisher MedRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.04.14.20053090
    Database COVID19

    Kategorien

To top